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(i.e., something comparable to the animal cap assay
commonly used in Xenopus studies).
Mammalian ES cells can differentiate into all embry-
onic cell types when injected into blastocyst-stage em-
bryos (Bradley et al., 1984). This pluripotency of ES cells
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Summary
Precise specification of a particular neuronal character-
istic, such as neurotransmitter choice, is crucial when
We have identified a stromal cell–derived inducing ac-
induced neurons are to be used for therapeutic applica-
tivity (SDIA) that promotes neural differentiation of
tions or basic neuroscience research. It is therefore pref-
mouse ES cells. SDIA accumulates on the surface of
erable to avoid RA treatment unless RA induces the
PA6 stromal cells and induces efficient neuronal differ-
particular type of neurons of one’s interest.
entiation of cocultured ES cells in serum-free condi-
In this report, we introduce an efficient system for in
tions without use of either retinoic acid or embryoid
vitro neural differentiation of mouse ES cells in a serum-
bodies. BMP4, which acts as an antineuralizing mor-
free condition that requires neither EBs nor RA treat-
phogen in Xenopus, suppresses SDIA-induced neu-
ment. We also discuss the possibilities for therapeutic
ralization and promotes epidermal differentiation. A
application of this method, by which dopaminergic neu-
high proportion of tyrosine hydroxylase-positive neu-
rons are efficiently produced.
rons producing dopamine are obtained from SDIA-
treated ES cells. When transplanted, SDIA-induced do-
Resultspaminergic neurons integrate into the mouse striatum
and remain positive for tyrosine hydroxylase expres-
Stromal Cells Produce Factors Supporting Neuralsion. Neural induction by SDIA provides a new power-
Differentiation of Mouse ES Cellsful tool for both basic neuroscience research and ther-
By using a coculture system, we screened various pri-apeutic applications.
mary culture cells and cell lines for activities promoting
neural differentiation of ES cells under serum-free condi-
Introduction tions (see the Experimental Procedures). Most of the cell
types screened, including mouse embryonic fibroblasts
During the last decade, much progress has been made (MEF), MDCK, and COS cells, did not significantly induce
in the molecular understanding of early neural differenti- neural markers such as NCAM (pan-neural) in the overly-
ation in Xenopus. Neural inducer molecules, such as ing ES cells (Figure 1A; arrows, negative colonies; inset,
Chordin, Noggin, and Follistatin, were identified, and phase contrast image of colonies). However, some stro-
several intracellular mediators of neural differentiation mal (or mesenchymal) cells promoted neural differentia-
have been characterized (for review, see Hemmati-Bri- tion when used as feeders. A low but significant number
vanlou and Melton, 1997; Sasai and De Robertis, 1997; of NCAM-positive colonies were observed in the pres-
Sasai, 1998). By contrast, relatively little is known about ence of OP9 (stromal line derived from mouse calvaria)
regulatory factors in mammalian neural induction. One and NIH3T3 (an embryonic fibroblast line) cells (data not
main reason for this is that good experimental systems shown). PA6 cells (stromal cells derived from skull bone
for in vitro neural differentiation are still lacking in mice marrow; Kodama et al., 1986) induced remarkably effi-
cient neural differentiation when cocultured with ES cells
(Figure 1B), resulting in 92% of colonies (n 5 200) be-# To whom correspondence should be addressed (e-mail: sasai@
frontier.kyoto-u.ac.jp). coming NCAM-positive by day 12.
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Figure 1. Neural-Inducing Factors Produced
by PA6 Stromal Cells
(A and B) NCAM staining of ES cell colonies
grown from a single cell for 8 days on MEF
and PA6 feeder cells, respectively. Inset,
phase contrast view.
(C and D) PA6-induced ES colonies double-
stained with TuJ and nestin antibodies, re-
spectively.
(E) The presynapse-specific marker synapto-
physin (Syn, green) was detected on the in-
duced neurons (TuJ, red).
(F) Percentages of TuJ-positive ES cell colo-
nies on gelatin, PA6, and PFA-fixed PA6 after
8 days of induction.
(G) TuJ staining of ES cells cultured on PFA-
fixed PA6 for 8 days.
(H) PA6 cells induce the neuronal marker TuJ
in cocultured ES cells even when separated
by a filter membrane (filter). The medium con-
ditioned with PA6 for 3 days (CM) did not
induce significant neural differentiation in ES
cells cultured on gelatin. Arrows, negative
colonies in immunostaining.
In these colonies, the majority of cells were stained duction. In contrast to the high NCAM-positive percent-
age, very few colonies expressed mesodermal markerswith either the neuronal marker TuJ (b-tubulin type III;
Figure 1C) or the neural precursor marker nestin (Figure such as PDGFR a, Flk1, and MF20 (all , 2% colonies,
n 5 100; data not shown) (Bader et al., 1982; Nishikawa1D). Very few colonies contained GFAP-positive cells
(2%, n 5 200). The TuJ-positive neurons also expressed et al., 1998). This is consistent with a previous report
showing that PDGFR a and Flk-1 are induced in ES cellsother neuronal markers such as MAP2 and neurofilament
(data not shown), and the presynaptic marker synapto- cocultured with OP9 cells but not in those cocultured
with PA6 cells (Kataoka et al., 1997). Thus, PA6 canphysin (green; Figure 1E) was detected on the induced
neurons (red, TuJ). To confirm that nestin-positive cells promote neural differentiation of cocultured ES cells
without inducing mesodermal markers.were neural precursors, cells were double-stained with
nestin and RC2, a marker for neuroepithelium and radial We next studied the role of PA6 in this induction.
When cultured on a gelatin-coated dish in the sameglia (Misson et al., 1988). All of the nestin-positive cells
were costained with RC2 antibody (n 5 200; data not medium but without PA6, ES cells differentiated into
neurons at a low frequency (Figure 1F, lane 1) comparedshown). We next tested whether neural differentiation
induced by PA6 was accompanied by mesodermal in- with the efficient rate obtained with ES cells cultured
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on PA6 (lane 2). This suggests that PA6 has an active 2A–2D). Since it was previously shown that BMP4, under
different conditions, could induce mesodermal differen-role in the promotion of neural differentiation of ES cells.
Interestingly, PA6 cells retained the neural-inducing ac- tiation (Johansson and Wiles, 1995; Kanatsu and Nishi-
kawa, 1996), we examined whether the suppression oftivity even after being fixed with paraformaldehyde (PFA)
(Figure 1F, lane 3, and Figure 1G). Furthermore, a similar neural fate by BMP4 was accompanied by induction
of nonneural ectoderm or mesoderm. BMP4 treatment ofactivity became evident on other PFA-fixed stromal
cells, including MEF, OP9, and NIH3T3 cells (data not ES cells on PA6 significantly increased the number of
colonies positive for the nonneural ectoderm markershown). These cells without fixation, as mentioned
above, showed weak neural-inducing activity if any at all. E-cadherin (Takeichi, 1988) (16% without BMP4, 75%
with BMP4, n 5 100; Figures 2E and 2F) without inducingIt is unlikely that the appearance of neuralizing activity is
simply due to artifacts resulting from PFA fixation as mesodermal markers such as PDGFR a, FLK1, or MF20
significantly (all , 5%; data not shown). Furthermore,this property was not observed in COS, MDCK, and 3Y1
cells regardless of fixation status (data not shown). This after 11 days of culture, BMP4 induced Keratin 14 (early
epidermal marker; Fuchs and Green, 1980) –positive col-suggests that PA6-like inducing activity is present in a
large variety of stromal cells. We speculate that stromal onies (0% without BMP4, 34% with BMP4, n 5 100;
Figures 2G and 2H). However, as compared to efficientcells other than PA6 simultaneously produce inducing
factors and inhibitory factors, the latter being inactivated E-cadherin induction in BMP4/SDIA-treated ES cells,
Keratin 14 induction was less dramatic (compare Fig-upon PFA fixation and missing in PA6. We named this
neural-inducing activity SDIA (stromal cell–derived in- ures 2F and 2H). We reasoned that BMP4/SDIA-treated
ES cells became nonneural ectoderm (or early epidermalducing activity).
As fixed cells can no longer secrete factors, the neu- precursor) cells that were not mature enough to express
Keratin 14 efficiently. Therefore, we attempted to pro-ral-inducing activity of PA6, at least in part, should be
mediated through something on the surface of stroma mote maturation by adding serum, which is a mixture
of various growth factors. Addition of serum during thecells (i.e., membrane-anchored molecule[s] or surface
matrix component[s]). We then tested whether direct last 3 days of induction promoted further epidermogen-
esis and generated large colonies with strong Keratinphysical contact between ES cells and PA6 cells was
essential for the induction. ES cell colonies were cul- 14 signals (47%, n 5 100; Figures 2I and 2J). These
results suggest that BMP4, in concert with SDIA, regu-tured on gelatin-coated dishes and separated from co-
cultured PA6 cells by a 0.4 mm filter membrane. In the lates an ectodermal binary decision for either epidermal
or neural fate in mouse ES cells, as it does in Xenopus.absence of physical contact, PA6 cells were still able
to induce significant neural differentiation of ES cells A time course study (Figure 3A) showed that neural dif-
ferentiation in ES cells was most sensitive to BMP4cultured on gelatin (Figure 1H, lane 2), indicating that
PA6 cells produce soluble inducing factor(s). However, during days 3–5 of the induction period. This correlates
well with the observation that mouse ES cells resemblePA6-conditioned medium could not elicit significant in-
duction (Figure 1H, lane 3). the inner cell mass (E4) in character (Bradley et al., 1984)
and that neural fate is thought to be determined duringTogether with the PFA fixation data, these results sug-
gest two possibilities as to the molecular nature of SDIA. gastrulation (E6.5zE8) (Kaufman and Bard, 1999), when
the BMP-neural inducer antagonism is believed to playOne is that SDIA consists of two different neural-induc-
ing factors, a cell surface-anchored factor and a labile a role.
One important question that arises is whether PA6-soluble factor. Another scenario might be that SDIA is
mediated by secreted factors, which are secondarily derived factors act by antagonizing BMP4 in a similar
manner as Chordin and Noggin (Hemmati-Brivanlou andtethered to the cell surface, as exemplified by Wnts and
FGFs (Iozzo, 1998; Bernfield et al., 1999). At present, we Melton, 1997). Northern blot and RT-PCR analyses
showed that PA6 cells do not express significant levelscannot exclude either possibility, but the latter appears
to be supported by our preliminary data that preincuba- of mouse Chordin, Noggin, or Cerberus (data not
shown). In our preliminary studies, neither transfectiontion of PA6 with heparin before fixation removes the
inducing activity from the cell surface (see the Experi- of pCMV-Chordin plasmid into ES cells nor addition of
Follistatin protein (up to 5000 ng/ml) to culture mediummental Procedures), as reported for Wnts (Bradley and
Brown, 1990). induced significant neural differentiation of ES cells. To
obtain more direct evidence, we actively blocked BMP
signaling by administering neutralizing BMPR-Fc recep-BMP4 Suppresses Neural Differentiation
tobody, which mimics the anti-BMP activities of neuraland Promotes Epidermogenesis
inducers (Figure 3B). BMPR-Fc (150 ng/ml) efficientlyof SDIA-Treated ES Cells
reversed the inhibitory effect of BMP4 (0.5 nM) on SDIA-In Xenopus, BMP4 inhibits neural differentiation of ani-
induced neural differentiation (lanes 3 and 4). However,mal cap ectoderm and promotes epidermogenesis (Sa-
the presence of BMPR-Fc did not affect the extent ofsai et al., 1995; Wilson and Hemmati-Brivanlou, 1995).
neural differentiation in the ES cells cultured on PA6,Neural inducers have been shown to act by antagonizing
fixed PA6, or gelatin (lanes 1, 2, and 5–8). BMPR-Fc didBMP in the extracellular space (Hemmati-Brivanlou and
not affect neural differentiation of ES cells on live MEFMelton, 1997; Sasai and De Robertis, 1997). We there-
(lanes 9 and 10). (This may suggest that lack of inducingfore tested whether BMP4 has a similar effect on the
activity in MEF cannot be explained by production ofneural differentiation of mouse ES cells induced by SDIA.
BMP-like activity.) These results demonstrate that inhi-Addition of 0.5 nM BMP4 resulted in clear suppression
of NCAM and nestin induction (,4%, n 5 100; Figures bition of BMP signaling is not sufficient to mimic SDIA.
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Figure 2. BMP4 Negatively Regulates Neural
Induction by SDIA and Promotes Epidermo-
genesis
ES cells cultured on PA6 cells for 8 days (A–F)
or 11 days (G–J) were stained with NCAM (A
and B), Nestin (C and D), E-cadherin (E and
F), or Keratin 14 (G–J) antibodies. In (B), (D),
(F), and (H)–(J), 0.5 nM BMP4 was added to
the medium. In (A)–(H), cells were cultured
in serum-free differentiation medium with or
without BMP4. In (I) and (J), 10% FCS was
added during the last 3 days of the 11 day
induction. (J) is an enlarged view of a colony
in (I). Arrows, negative colonies in immuno-
staining.
Taken together, BMP antagonism is unlikely to explain cells; bFGF, FGF8, Shh, a combination of FGF8 and Shh,
HGF, EGF, PDGF, LIF, or LiCl (mimicking Wnt signaling).the neuralizing activity of SDIA.
The molecular nature of SDIA remains to be identified. As SDIA is not detected in the conditioned medium (Fig-
ure 1H), it may be necessary to identify the SDIA-produc-Our preliminary study has shown that none of the follow-
ing treatments promoted neural differentiation of ES ing gene by functional expression screening.
Generation of DA Neurons with SDIA
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dopaminergic as they were negative for DBH (dopa-
mine-b-hydroxylase; marker for norepinephrine and epi-
nephrine neurons) even after 13 days of induction (Figure
4B). Consistent with the TH staining, the mesencephalic
dopaminergic neuron markers Nurr1 (Zetterstrom et al.,
1997) and Ptx3 (Smidt et al., 1997) were induced in SDIA-
treated ES cells (Figure 4C).
To further confirm the generation of dopaminergic
neurons, we examined dopamine production in the in-
duced neurons by using reverse phase HPLC. In re-
sponse to a depolarizing stimulus (56 mM K1), ES cell–
derived neurons released a significant amount of
dopamine into the medium (7.7 pmol/106 cells; the dopa-
mine peak is shown as DA in Figure 4D). Dopamine
derivatives, 3,4-dihydroxyphenylacetic acid (DOPAC)
and homovanillic acid (HVA), were also detected (2.5
pmol and 4.0 pmol/106 cells, respectively). These data
show that functional neurons producing dopamine were
generated with this method.
Although RA treatment of EBs is a commonly used
method for inducing neural differentiation (Bain et al.,
1995), such efficiency in the induction of dopaminergic
neurons has not been previously reported. We treated
EBs with 1 mM RA as described previously (4–41
method) (Bain et al., 1995) and examined the dopaminer-
gic marker TH. Less than 1% of EBs contained cells
positive for TH. Interestingly, RA treatment (0.1–1 mM;
days 4–8) suppressed SDIA-mediated induction of TH-
positive neurons without reducing the number of TuJ-Figure 3. Suppression of Neural Differentiation by BMP4: Temporal
positive neurons (data not shown). These results indi-Requirement and Blocking Study
cate that the absence of RA from the culture medium(A) Time window of susceptiveness to antineuralizing activity of
BMP treatment. ES cells were cultured on PA6 for 8 days, and TuJ- is required for successful induction of dopaminergic
positive colonies were counted. BMP4 (0.5 nM) was added to the neurons.
medium during the days indicated below the bar.
(B) BMPR-Fc (150 ng/ml) was added to the medium (1) or not (2).
Implantation of SDIA-Induced NeuronsAlthough BMPR-Fc sufficiently antagonized antineuralizing activity
into the Mouse Brainof 0.5 nM BMP4 (PA6 1 BMP), BMPR-Fc did not cause significant
change in neuronal differentiation of ES cells cultured on PA6, fixed The data above indicate that the in vitro neural differenti-
PA6, MEF, or gelatin. ation system mediated by SDIA may prove a good
source of mesencephalic-type dopaminergic neurons,
which are necessary for cell transplantation therapy of
Parkinsonism. Therefore, we next tested whether SDIA-A High Proportion of Dopaminergic Neurons
in SDIA-Induced Neurons from ES Cells treated ES cells could be integrated into the mouse
striatum after implantation. ES cell colonies were cul-Immunohistochemical analyses of the characteristics of
SDIA-induced neurons revealed that 92% of colonies tured on PA6 cells for 12 days, and detached en bloc
from the feeders by a mild protease treatment withoutcontained tyrosine hydroxylase (TH)–positive neurons
(n 5 200; Figure 4A). This value was much higher than EDTA. In order to enrich for postmitotic neurons by elimi-
nating mitotic cells, the SDIA-treated ES cells werethose for GABAergic, cholinergic, and serotonergic neu-
ron markers (43%, 28%, and 7%, respectively). To esti- treated with mitomycin C (MMC) before grafting.
The isolated ES cell colonies were then implantedmate the efficacy of dopaminergic neuron induction at
the cell level, the numbers of TuJ-, nestin-, and TH- into the mouse striatum, which had been treated with
6-hydroxydopamine (6-OHDA). 6-OHDA largely depletedpositive cells were counted in randomly selected ES cell
colonies on induction day 12. TuJ-positive neurons and dopaminergic neuron projections in the nigro-striatal
system on the injected side (Figures 5A and 5B). Ipsilat-nestin-postive cells represented 52% 6 9% and 47% 6
10% of total cells, respectively. TH neurons occupied eral implantation of SDIA-induced neurons significantly
restored TH-positive areas in and around the DiI-positive30% 6 4% of TuJ-positive neurons (n 5 5050; i.e., 16%
of total cells). This value is again significantly higher graft (Figures 5C and 5D). Control medium injection did
not cause any changes in TH-positive regions (data notthan percentages of GABAergic, cholinergic, and sero-
tonergic neurons in TuJ-positive neurons (18% 6 8%, shown). Confocal microscopy images of the graft are
shown in Figures 5E and 5F. After implantation of 4 39% 6 5%, and 2% 6 1%, respectively) at the cell level.
A time course study showed that TH-positive neurons 105 SDIA-treated ES cells, 3.9 6 0.6 3 104 grafted cells
(DiI; Figure 5E) were found in the brain on day 15, andappeared between days 6–8 of the induction period,
following the appearance of nestin and tubulin markers 74% of them were TuJ-positive neurons (data not
shown). Among them, 1.3 6 0.1 3 104 TH-positive neu-(Figure 4B). These TH-positive neurons proved to be
Neuron
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rons (green in Figure 5F) were present. As the injected
ES cell colonies initially contained 6 3 104 TH-positive
cells, the survival rate of TH-positive neurons was z22%
after these procedures. No teratoma formation was ob-
served in the grafted tissue by histological analyses (n 5
5; data not shown).
Discussion
Neuronal Differentiation Induced by SDIA
In this study, we have introduced a new method for
generating neurons from ES cells by using PA6-derived
SDIA. This method is technically simple, and the induc-
tion is efficient and speedy. The SDIA method does
not involve EB formation or RA treatment, and each
differentiating colony grows from a single ES cell in two
dimensions under serum-free conditions. Because of
these features, the SDIA method has advantages over
the EB/RA methods when used for detailed analyses of
differentiation, as exemplified by the role of BMP4 in
this study (Figures 2 and 3).
We found that mesencephalic dopaminergic neurons
can be efficiently produced by our method. Recently,
it was reported that dopaminergic neurons could be
generated from neural precursor cells amplified from
EBs (Lee et al., 2000). In contrast to our single-step
method, they used the following four steps for the
production of dopaminergic neurons: (1) generation of
EBs without RA treatment in a serum-containing me-
dium; (2) selection of nestin-positive cells; (3) expansion
of nestin-positive cells with bFGF; and (4) induction of
neuronal differentiation in serum-free medium. Since
only small numbers of neural precursors are present
in RA-untreated EBs, one needs to select and amplify
nestin-positive cells for a long time (14 days) in this
method before inducing differentiation (.24 days in to-
tal) (Lee et al., 2000). The avoidance of RA treatment
concurs with our finding that RA is a negative factor for
dopaminergic neuron generation. This four-step method
produced TH-positive neurons at an efficiency of z7%
of TuJ-positive neurons in conventional medium. When
Shh, FGF8, and ascorbate were added, the production
increased to z30%, which is comparable to the effi-
ciency of our method.
The molecular basis of dopaminergic neuron induc-
tion in the SDIA method remains to be understood. We
have tested those factors that have been implicated in
the regulation of dopaminergic differentiation (Hynes
and Rosenthal, 1999), such as FGF8, Shh, IL1, IL11, LIF,
GDNF, or neutralizing antibodies of FGF8 and Shh. So
far, we have not observed any marked effects on the
induction of dopaminergic neurons. Interestingly, as dis-Figure 4. SDIA-Induced Neurons Contain a High Proportion of Do-
cussed above, the efficiency of dopaminergic neuronpaminergic Neurons
induction in the SDIA method is as high as the maximum(A) Immunostaining of SDIA-induced neurons (day 10) with anti-TH
antibody. efficiency obtained in the four-step method with Shh,
(B) Time course study of appearance of ES cell colonies with TH, FGF8, and ascorbate treatment. One possible explana-
DBH, TuJ, and Nestin-like immunoreactivities. Nestin appeared on tion for this is that the differentiation of dopaminergic
day 3, TuJ on day 5, and TH between day 6–8 (the first induction
day defined as day 0). DBH-positive neurons were not observed.
(C) RT-PCR analysis with markers (Nurr1 and Ptx3) of mesencephalic
dopaminergic neurons (day 12).
(D) Detection of dopamine secreted by SDIA-induced neurons. Re- phenylacetic acid and homovanillic acid, respectively. The inset
verse phase HPLC pattern with electrochemical detection is shown. shows chromatography of control medium (conditioned with feeder
DA, DOPAC, and HVA indicate peaks of dopamine, 3,4-dihydroxy- cells only).
Generation of DA Neurons with SDIA
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Figure 5. Integration of SDIA-Induced Dopa-
minergic Neurons in the Mouse Striatum
(A) TH staining of normal mouse striatum.
(B) Injection of 6-OHDA depleted TH-like im-
munoreactivity from the striatum (1 week
after drug treatment).
(C and D) SDIA-induced ES cells were im-
planted into 6-OHDA-lesioned striatum 3
days after drug treatment. TH-positive region
(green) recovered in and around the im-
planted cells (red, [D]) in the striatum 1 week
after grafting. In our experiment, DiI labeled
efficiently the cell bodies but not the axons.
As a result, TH signals in the neurites of the
grafted neurons expanded beyond the DiI
positive area.
(E and F) Confocal microscopy images of the
graft after 2 weeks. TH-positive neurons
(green) in the striatum were derived from
grafted ES cells (red, DiI). In (F), in addition
to cell bodies, TH signals were also found in
numerous neurites (green speckles) gener-
ated in the graft.
ST, striatum; NA, nucleus accumbens.
neurons in the SDIA system may be regulated somehow brates, the organizer is thought to play an important role
in an intrinsic manner (e.g., the default status), although in the induction and patterning of the CNS (Sasai and
further study is needed to address this question. De Robertis, 1997). In mice, the primitive node is shown
The SDIA-mediated in vitro differentiation method to be the organizer, and heterotopic graft of the node
should provide a convenient experimental system for induces a secondary axis, including ectopic formation
many aspects of neuroscience research, such as neural of neural tissues (Beddington, 1994). Interestingly, the
development, cell biology, neuropharmacology, and CNS tissues can form in the mouse embryo even in the
electrophysiology. absence of the organizer. Most CNS structures form in
the HNF3b-/- mouse, which lacks the node (Klingensmith
et al., 1999). Furthermore, noggin/chordin-compoundPossible Roles of SDIA-like Activity
null mutant mice show severe defects in the forebrain,in Early Neural Development
but not in the CNS tissues posterior to the midbrainThe time course of neural marker induction by SDIA
(Bachiller et al., 2000). These results suggest that some(Figure 4B) is reminiscent of that observed in the devel-
factors other than the classical organizer-derived neuraloping central nervous system (CNS), at least in part. For
inducers (i.e., BMP antagonists) play an important roleinstance, in this method, TH-positive neurons appear
in the induction of mammalian neural tissues.on the induction days 6–8, while TH expression is first
In our experiments, SDIA-induced neural differentia-detected in the fetal mouse midbrain on E11.5 (Foster
tion of ES cells was strongly suppressed by a low dose ofet al., 1988). Given that ES cells behave like the inner
BMP4 (Figure 2). However, addition of a BMP4 blockingcell mass (E4), the period required for TH induction in
agent alone did not sufficiently induce neural differentia-vitro correlates well to that seen in the embryo.
tion (Figure 3B), although low levels of BMP2 and BMP4One important question is whether an SDIA-like activ-
ity functions in vivo during early neurogenesis. In verte- are present in ES cells (Johansson and Wiles, 1995;
Neuron
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Winnier et al., 1995). Thus, inhibition of BMP signals is Second, we should develop an even more efficient way
to enrich for dopaminergic neurons from the total popu-essential but not sufficient for mouse ES cells to differen-
tiate into neural cells. One possible explanation is that lation of differentiated ES cells. Sorting by flow cytome-
try or separating with magnetic beads should be feasiblesome additional factors such as SDIA are required for
neural differentiation before mouse cells make the neu- once appropriate surface antigens for early dopaminer-
gic neurons become available. Third, we need to testral/epidermal binary decision in a BMP-dependent man-
ner. Consistent with this idea, the SDIA-treated cells the safety of ES cell therapy in long-term implantation
studies. It may be beneficial to select only postmitoticacquire their highest sensitivity to BMP4 subsequent to
the onset of nestin expression (day 3; Figures 3A and neurons by eliminating dividing cells with MMC (and/or
Ara C) before grafting to prevent tumor formation, as4B). This indicates that SDIA has already exerted some
effects (nestin induction) before the cells react to BMP we did in this study.
To explore further possibilities for therapeutic applica-signals.
An interesting observation regarding SDIA and BMP4 tion and basic neuroscience research, it will be worth-
while to study how to regulate the differentiation ofis that SDIA seems to suppress the mesodermalizing
effects of BMP4 on ES cells. BMP4 promotes mesoder- SDIA-treated ES cells into many specific types of the
CNS neurons.mal differentiation of mouse ES cells and epiblasts cul-
tured in serum-free media (Johansson and Wiles, 1995;
Experimental ProceduresKanatsu and Nishikawa, 1996), as it does in the animal
cap assay (Dale et al., 1992). However, when BMP4
Induction of Neural Differentiation of ES Cells
is combined with SDIA, epidermogenesis, rather than Undifferentiated ES cells (CCE or EB5) were maintained on gelatin-
mesodermal differentiation, is promoted (Figure 2). One coated dishes in G-MEM supplemented with 1% FCS (JRH), 10%
KSR (GIBCO-BRL), 2 mM glutamine, 0.1 mM nonessential aminoexplanation for this is that SDIA acts by stabilizing the
acids, 1 mM pyruvate, 0.1 mM 2-mercaptoethanol (2-ME), and 2000ectodermal fate and protecting from mesodermalizing
U/ml LIF (GIBCO-BRL). EB5 cells (a kind gift of Dr Hitoshi Niwa,influences. If so, the following scenario might be applica-
Osaka University) carry the blasticidin S-resistant selection markerble to the mechanism of neuralization occurring in SDIA-
gene driven by the Oct3/4 promoter (active under the undifferenti-
treated ES cells. First, ES cells cultured on PA6 move ated status) and were maintained in medium containing 20 mg/ml
in an ectodermal direction under the influence of SDIA. blasticidin S to eliminate differentiated cells. EB5 is a subline derived
from E14tg2a ES cells (Hooper et al., 1987) and was generated bySDIA-treated ES cells then adopt a default neural status
targeted integration of Oct-3/4-IRES-BSD-pA vector (Niwa et al.,unless they receive a sufficient level of BMP4 signals.
2000) into the Oct-3/4 allele.In accordance with this model, explants of pre-streak
For differentiation, ES cells were cultured to form colonies fromepiblast (E 6.0) differentiate efficiently into neural cells
a single cell on various feeder cells in G-MEM medium supple-
on PA6 unless exogenous BMP4 is added to the culture mented with 10% KSR, 2 mM glutamine, 1 mM pyruvate, 0.1 mM
media (H. K., K. M., and Y. S., unpublished data). How- nonessential amino acids, and 0.1 mM 2-ME (“differentiation me-
dium”). It was essential to remove serum from the media since theever, as the molecular nature of SDIA remains to be
addition of FCS strongly inhibited neural differentiation. LIF alsoelucidated, we must await further study to judge this
suppressed neural differentiation. ES cell colonies were grown at aproposition and to understand the relevant roles of SDIA
density of 1 3 103 colonies per 3 cm dish. Medium change wasin the embryo.
performed on day 4 and every other day following that. EB5 and
CCE behaved similarly in this study, and the data shown in this
report were from experiments with EB5 cells. Reverse phase–HPLCApplication to Cell Replacement Therapy
analysis of dopamine was performed by using an electrochemicalAs this method produces a high yield of mesencephalic
detector (the Monoamine Analysis System, Eicom Corp., Kyoto,dopaminergic neurons, SDIA-induced neurons may pro-
Japan.) ES cells were cultured on PA6 for 8 days in differentiationvide a noninvasive alternative to embryonal brain tissues
medium and for an additional 6 days in G-MEM supplemented with
and neural stem cells for neuronal replacement therapy N2, 100 mM tetrahydrobiopterin and 200 mM ascorbate, 2 mM gluta-
of Parkisonism (Lindvall, 1999; Gage, 2000). Long-term mine, 1 mM pyruvate, 0.1 mM nonessential amino acids, and 0.1
mM 2-ME. After rinsing twice with HBSS, cells were incubated withsurvival of SDIA-induced neurons and its functional con-
HBSS containing 56 mM K1 for 15 min. The medium was thensequences such as motor recovery are currently being
collected, stabilized with 0.4 M perchloric acid and 5 mM EDTA,investigated in parkinsonian mice. One advantage of
and kept at 2808C until being used for analysis.using ES cells over neural stem cells is that genetic
manipulations such as modifying histocompatibility are Immunostaining and RNA Analysis
theoretically feasible by homologous recombination. Immunohistochemistry was performed with the following antibod-
ies; anti-NCAM, anti-TH, anti-GAD (GABAergic marker), and anti-Before SDIA-treated ES cells can be applied to cell
VAChT (cholinergic marker) (Chemicon), TuJ (Babco), anti-nestinreplacement therapy of Parkinsonism, important techni-
(Pharmingen), anti-GFAP and anti-synaptophysin (Sigma), RC2 andcal advances must be made at least in the following
MF20 (Developmental Studies Hybridoma Bank), anti-PDGFR alphasteps. First, we must test whether human ES cells differ-
and anti-Flk1 (Nishikawa et al., 1998), anti-E-cadherin (Takara), anti-
entiate into dopaminergic neurons in a manner similar Keratin 14 (Biomedia), anti-serotonin (Dia Sorin), and anti-DBH
to mouse ES cells. We infer that the same principles (PROTOS Biotech). Immunoreactivity of each antibody was con-
firmed with appropriate positive control tissues under the sameshould be applicable to human cells, as the early devel-
conditions. RT-PCR was performed as described previously (Sasaiopment phase relevant to ES cell differentiation exhibits
et al., 1995), except for addition of 5% DMSO in the case of Ptx3minimal differences across mammalian species in gen-
cDNA detection to counter the high GC content. The primers usederal. However, minor modifications may be necessary
are as follows; Nurr1, TGAAGAGAGCGGACAAGGAGATC and
as some properties of human ES cells differ in culture TCTGGAGTTAAGAAATCGGAGCTG; Ptx3, AGGACGGCTCTCTGAA
conditions from mouse ones, such as LIF-independent GAA and TTGACCGAGTTGAAGGCGAA; G3PDH, GACCACAGTCC
ATGCCATCACT and TCCACCACCCTGTTGCTGTAG.growth (Thomson et al., 1998; Reubinoff et al., 2000).
Generation of DA Neurons with SDIA
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PFA Treatment and Transfilter Assay of SDIA sor Kazuhiko Umesono (Kyoto University), who passed away while
this project was under way.PA6 cells were grown to confluency, fixed with 4% PFA for 15 min
at room temperature, and rinsed with PBS several times. ES cells
were seeded on the fixed feeder cells in a similar manner to live Received July 17, 2000; revised August 15, 2000.
feeder cells. For pretreatment with heparin, PA6 cells were cultured
for 2 days in the presence of 200 ng/ml heparin, rinsed with PBS, References
and then fixed with PFA.
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